Medicare Payment for Opioid Treatment Programs.

ABSTRACT:

Importance

Medicare began paying for medications for opioid use disorder (MOUD) at opioid treatment programs (OTPs) that dispense methadone and other MOUD in January 2020. There has been little research describing the response to this payment change and whether it resulted in more patients receiving MOUD or just a shift in who pays for this care.

Objective

To describe how many and which Medicare beneficiaries receive care from OTPs and how this compares to those receiving MOUD in other settings.

Design, setting, and participants

This cross-sectional study included all patients receiving MOUD care identified in 2019-2022 100% US Medicare Parts B and D claims. Patients receiving care in an OTP who were dually insured with Medicare and Medicaid in the 2019-2020 Transform

SUBMITTER: Nakamoto CH 

PROVIDER: S-EPMC11259898 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature